Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Contineum Therapeutics, Inc. | Chief Scientific Officer | Class A Common Stock | 170K | $2.89M | $17.05 | Nov 18, 2024 | Direct |
Contineum Therapeutics, Inc. | Chief Scientific Officer | Class A Common Stock | 3.9K | $66.5K | $17.05 | Nov 18, 2024 | By Spouse |
Contineum Therapeutics, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 100K | May 24, 2024 | Direct | ||
Contineum Therapeutics, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 3.7K | May 24, 2024 | By Spouse |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTNM | Contineum Therapeutics, Inc. | Nov 18, 2024 | 2 | -$101K | 4 | Nov 20, 2024 | Chief Scientific Officer |
CTNM | Contineum Therapeutics, Inc. | May 24, 2024 | 2 | $0 | 4 | May 29, 2024 | Chief Scientific Officer |
CTNM | Contineum Therapeutics, Inc. | Apr 4, 2024 | 0 | $0 | 3 | Apr 4, 2024 | Chief Scientific Officer |